Welcome to LookChem.com Sign In|Join Free
  • or
Benzoic acid, 3-[[(1,1-dimethylethoxy)carbonyl]amino]-2,4-bis(methoxymethoxy)-, methyl ester is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

919286-18-3

Post Buying Request

919286-18-3 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

919286-18-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 919286-18-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,1,9,2,8 and 6 respectively; the second part has 2 digits, 1 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 919286-18:
(8*9)+(7*1)+(6*9)+(5*2)+(4*8)+(3*6)+(2*1)+(1*8)=203
203 % 10 = 3
So 919286-18-3 is a valid CAS Registry Number.

919286-18-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 20, 2017

Revision Date: Aug 20, 2017

1.Identification

1.1 GHS Product identifier

Product name 3-tert-butoxycarbonylamino-2,4-bis-methoxymethoxy-benzoic acid methyl ester

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:919286-18-3 SDS

919286-18-3Relevant academic research and scientific papers

Total synthesis of platensimycin and related natural products

Nicolaou,Li, Ang,Edmonds, David J.,Tria, G. Scott,Ellery, Shelby P.

supporting information; experimental part, p. 16905 - 16918 (2010/04/04)

Platensimycin is the flagship member of a new and growing class of antibiotics with promising antibacterial properties against drug-resistant bacteria. The total syntheses of platensimycin and its congeners, platensimycins B1 and B3, platensic acid, methyl platensinoate, platensimide A, homoplatensimide A, and homoplatensimide A methyl ester, are described. The convergent strategy developed toward these target molecules involved construction of their cage-like core followed by attachment of the various side chains through amide bond formation. In addition to a racemic synthesis, two asymmetric routes to the core structure are described: one exploiting a rhodium-catalyzed asymmetric cycloisomerization, and another employing a hypervalent iodine-mediated de-aromatizing cyclization of an enantiopure substrate. The final two bonds of the core structure were forged through a samarium diiodide-mediated ketyl radical cyclization and an acid-catalyzed etherification. The rhodium-catalyzed asymmetric reaction involving a terminal acetylene was developed as a general method for the asymmetric cycloisomerization of terminal enynes.

Total synthesis of platensimycin

Nicolaou,Li, Ang,Edmonds, David J.

, p. 7086 - 7090 (2007/10/03)

(Chemical Equation Presented) Beat the superbugs: The newly discovered antibiotic platensimycin (1) promises to combat current drug-resistant infections. The natural product shows potent activity against Gram-positive bacteria and contains a novel molecul

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 919286-18-3